The ACACIA-HCM trial met both primary endpoints, potentially opening treatment to a new population of heart disease patients ...

Myqorzo’s success in “non-obstructive” hypertrophic cardiomyopathy separates it from Bristol Myers Squibb’s rival Camzyos and ...

Georgina, known as Gina, says a quick and free test at Everton in the Community’s BEAT Breathlessness Hub “saved” her life ...

Recent data underscores the need for improved primary care detection of heart failure with preserved ejection fraction.

A novel transcatheter mitral valve replacement system designed for left atrial fixation rather than subvalvular fixation ...

The PRAETORIAN score is a noninvasive test that gives a score from 30 to 900, which can be interpreted as low risk (<90 ...

I’m a 75-year-old woman who’s in very good health. Since my early 50s, I’ve had issues with my cholesterol. My doctor has put ...

A new study suggests severe obesity may weaken heart muscle cells in people with heart failure with preserved ejection ...

Background Patients with adult congenital heart disease (ACHD) frequently develop late complications despite early surgical ...

Affinia Therapeutics ("Affinia"), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating ...

With more underclassmen picking the transfer portal over the NBA Draft than ever before, here are several noteworthy ...